Why Moderna Stock Is Rising Today
Shares of Moderna (NASDAQ: MRNA) were rising 2% as of 11:04 a.m. EDT on Friday. The company didn't report any new developments. Instead, the stock appears to still be benefiting from good news earlier this week as well as strength in the overall stock market.
There were two positive developments for Moderna this week. The company won a deal with the European Commission to supply another 150 million doses of its COVID-19 vaccine in 2022. And investors were relieved that the only action taken in response to a potential link between messenger RNA COVID vaccines and rare heart inflammation issues was that the Food and Drug Administration is adding a warning to the vaccines' labels.
Image source: Getty Images.
Source Fool.com
